focus -WSS

focus

author：hotspot 2025-10-02 09:47:35 - browse：81

Silver Apple Watch — Charles Rex Arbogast/AP

Rune Labs, maker of an Apple Watch app that can track symptoms related to Parkinson’s disease, announced Thursday $12 million in funding led by Nexus NeuroTech, a new venture capital fund focused on brain disorders.

Rune in 2022 received Food and Drug Administration clearance for StrivePD, an Apple Watch app that uses the device’s sensors to track two Parkinson’s-related symptoms: tremors and dyskinesia, or the involuntary movements that are a side effect of medication. The app also collects sleep, activity, and medication data and can serve as a focal point for education and care management for people with Parkinson’s. The app can help users make day-to-day decisions about lifestyle and medication and help inform care decisions by providers. Rune also works with drug companies developing treatments for the disease.

Rune Labs CEO Brian Pepin told STAT the company will use the funds to push the adoption of its technology among health plans that can use it to manage care for their members with Parkinson’s disease. The company last year finalized a deal with “a large California health system” and now hopes to go out and sell to more organizations that have Medicare Advantage plans or other at-risk populations they serve. This requires an investment in business development staff and people to manage those relationships.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Study fuels hope CAR

WSS

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

As AI regulations shape up, health tech startups beg for clarity

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Medicare Advantage enrollment hits roughly 33.4 million

Ohio train derailment: Experts on toxic chemical risks

Abridge raises $150m as clinical notes automation market heats up

Wikipedia

focus

explore

Jerome Adams on the need for new antivirals for Covid

CDC advisory group OKs chikungunya vaccine

Hollywood unions extend contract negotiations for actors

MD Anderson's Padmanee Sharma responds to research credit suit

Medicare details structure of new drug price negotiation program

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

Heart attack and stroke risk calculators need revising

New study raises questions about niacin and heart health

State Dept. review finds Biden bears some blame for Afghanistan failures

New study raises questions about niacin and heart health

knowledge

A new drug could help frostbite victims avoid its ravages

Change Healthcare cyberattack shows risk of industry consolidation

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Medicare isn't yet testing food as medicine

Medicare Advantage enrollment grows 7.1% to 33.4 million people

leisure time

hotspot

focus

hotspot